6-azido-3,5-di-O-benzoyl-6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose | 103973-81-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 6-azido-3,5-di-O-benzoyl-6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose
• CAS: 103973-81-5
• 化学式: C₂₃H₂₃N₃O₇
• 分子量: 453.452
• InChiKey: ALBOGBOFGHWFIC-NFSXTHTRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.62
• 重原子数：
  33.0
• 可旋转键数：
  7.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  129.05
• 氢给体数：
  0.0
• 氢受体数：
  8.0

反应信息

• 作为反应物：
  描述：

  6-azido-3,5-di-O-benzoyl-6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose 在 三氟甲磺酸三甲基硅酯 、 硫酸 、 碘 、 六甲基二硅氮烷 作用下， 以 吡啶 、 二氯甲烷 为溶剂， 反应 56.5h， 生成 4-amino-1-(6-azido-2,3,5-tri-O-benzoyl-6-deoxy-β-D-glucofuranosyl)-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine
  参考文献：
  名称：

  Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines

  摘要：

  7-(6-amino-6-deoxy-beta-D-glucofuranosyl)-5-cyanopyrrolo[2,3-d]pyrimidine (22) and 7-(3-amino-methyl-3-deoxy-beta-D-allofuranosyl)-5-cyanopyrrolo [2,3-d]pyrimidine (28) were synthesized by sequentially coupling silylated 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine with the corresponding protected sugars 9 and 17, followed by deblocking and catalytic hydrogenation. Conversion of the 5-nitrile in 22 and 28 into a carboxamide gave the corresponding sangivamycin derivatives 23 and 29. Whereas 5'-aminomethyl nucleosides 22 and 23 inhibited the growth of four different human tumor cell lines at mu M concentrations, the 3'-aminomethyl analogs 28 and 29 were much less active against these cells. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0008-6215(98)00098-6
• 作为产物：
  描述：

  O3,O5-dibenzoyl-O1,O2-isopropylidene-O6-(toluene-4-sulfonyl)-α-D-glucofuranose 在 叠氮化锂 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 以78.3%的产率得到6-azido-3,5-di-O-benzoyl-6-deoxy-1,2-O-isopropylidene-α-D-glucofuranose
  参考文献：
  名称：

  Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines

  摘要：

  7-(6-amino-6-deoxy-beta-D-glucofuranosyl)-5-cyanopyrrolo[2,3-d]pyrimidine (22) and 7-(3-amino-methyl-3-deoxy-beta-D-allofuranosyl)-5-cyanopyrrolo [2,3-d]pyrimidine (28) were synthesized by sequentially coupling silylated 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine with the corresponding protected sugars 9 and 17, followed by deblocking and catalytic hydrogenation. Conversion of the 5-nitrile in 22 and 28 into a carboxamide gave the corresponding sangivamycin derivatives 23 and 29. Whereas 5'-aminomethyl nucleosides 22 and 23 inhibited the growth of four different human tumor cell lines at mu M concentrations, the 3'-aminomethyl analogs 28 and 29 were much less active against these cells. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0008-6215(98)00098-6